Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
206.20    3.40 (1.68%)
Bid:
204.40
Ask:
206.40
Spread: 2.00 (0.978%)
Market Cap: £1.78b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Board Appointment

1 Mar 2017 07:00

RNS Number : 1207Y
Premier Foods plc
01 March 2017
 

 

 

Premier Foods plc

("Premier Foods" the "Company")

 

1 March 2017

Board Appointment

Premier Foods plc is pleased to announce the appointment of Daniel Wosner as a Non-Executive Director of the Company from 1st March 2017. Daniel is Managing Director and Head of Europe at Oasis Management Company Limited ("Oasis"), an international investment firm and the Company's second largest shareholder. Before joining Oasis in 2016, Daniel held senior investment banking roles at Barclays and Lehman Brothers.

David Beever, Chairman of Premier Foods, said:

"We are pleased to welcome Daniel Wosner of Oasis to the board as a non-executive director and look forward to working with him to drive the Company's long-term value and enhance value for all shareholders. Daniel's perspective and experience will be a valuable addition to the team as we continue our effort to maximise the potential of our category leading brands, strong customer partnerships and supply chain expertise."

Daniel Wosner added:

"We appreciate the constructive engagement that we have had with Premier Foods Chairman David Beever and the Executive Leadership Team, and I welcome the opportunity to join the Board. I look forward to working with Chief Executive Officer Gavin Darby, and his colleagues to achieve the full potential and value from the Company's outstanding brand portfolio."

Seth Fischer, Chief Investment Officer & Founder of Oasis, commented:

"We have followed Premier Foods for several years and are optimistic about the long-term prospects of the Company. As significant investors, we are fully committed to building long-term value for all shareholders."

Accordingly, the Company and Oasis have today entered into a customary relationship agreement, a summary of the terms is available on the Company's website. Some of the key terms are set out below.

· Daniel will be appointed to the Remuneration Committee of the Board

· Oasis will acquire in aggregate 10% of the ordinary share capital of the Company by 30th June 2018

· The relationship agreement with Oasis and Daniel's tenure as a Non-Executive Director will continue until the day following the 2019 AGM, unless extended

· For the term of the relationship agreement, Oasis is to hold a minimum of 7% and a maximum of 15% shareholding in the Company

No further information is required to be disclosed pursuant to LR 9.6.13 R.

 

For further information please contact:

Alastair Murray, Chief Financial Officer

Andrew McDonald, General Counsel & Company Secretary

Richard Godden, Head of Investor Relations

+44 (0) 1727 815850

+44 (0) 1727 815850

+44 (0) 1727 815850

 

 

Maitland

Kate O'Neill

Tom Eckersley

+44 (0) 20 7379 5151

Notes to editors:

A summary of terms of the relationship agreement can be found on the Company's website:

http://www.premierfoods.co.uk/investors/shareholder-centre

About Oasis Management

Oasis Management Company Ltd. manages private investment funds focused on opportunities in a wide array of asset classes across countries and sectors. Oasis was founded in 2002 by Seth Fischer, who leads the firm as its Chief Investment Officer. More information available at https://oasiscm.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFLDFVITFID
Date   Source Headline
1st Mar 20239:00 amRNSTotal Voting Rights
2nd Feb 20233:25 pmRNSDirector/PDMR Shareholding
1st Feb 20231:29 pmRNSDirector/PDMR Shareholding
1st Feb 20239:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSTrading Statement
3rd Jan 20239:00 amRNSTotal Voting Rights
20th Dec 20229:05 amRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSTotal Voting Rights
24th Nov 202210:46 amRNSDirector Declaration
16th Nov 20227:00 amRNSHalf-year results
8th Nov 20227:00 amRNSNotice of Results
1st Nov 20229:00 amRNSTotal Voting Rights
3rd Oct 202210:00 amRNSBlock listing Interim Review
3rd Oct 20229:00 amRNSTotal Voting Rights
30th Sep 20222:44 pmRNSDirector Declaration
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20222:41 pmRNSCompletion of The Spice Tailor acquisition
25th Aug 20227:00 amRNSDirector/PDMR Shareholding
24th Aug 202210:00 amRNSChange of Auditor
2nd Aug 20229:46 amRNSDirector Declaration
1st Aug 20229:00 amRNSTotal Voting Rights
29th Jul 202210:34 amRNSHolding(s) in Company
25th Jul 20227:00 amRNSAcquisition of The Spice Tailor
20th Jul 20224:07 pmRNSResult of AGM
20th Jul 20227:00 amRNSQ1 Trading Update
1st Jul 20228:30 amRNSTotal Voting Rights
22nd Jun 20223:05 pmRNSDividend Record Date Confirmation
10th Jun 20223:04 pmRNSDirector/PDMR Shareholding
6th Jun 202211:35 amRNSNotice of AGM
1st Jun 20229:00 amRNSTotal Voting Rights
27th May 202211:00 amRNSDirectorate Change
25th May 202212:25 pmRNSHolding(s) in Company
25th May 20227:00 amRNSHolding(s) in Company
19th May 202210:02 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSPreliminary Results
13th May 20222:21 pmRNSRemuneration Committee Chair
3rd May 20229:00 amRNSTotal Voting Rights
27th Apr 202212:14 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSDirectorate Change
21st Apr 20227:00 amRNSNotice of Results
8th Apr 20229:08 amRNSHolding(s) in Company
1st Apr 20228:24 amRNSBlock listing Interim Review
1st Apr 20228:00 amRNSTotal Voting Rights
10th Mar 20221:02 pmRNSNon-Executive Director Appointment
3rd Mar 202212:47 pmRNSDirector/PDMR Shareholding
1st Mar 20229:00 amRNSTotal Voting Rights
25th Feb 20222:29 pmRNSDirector/PDMR Shareholding
9th Feb 20223:17 pmRNSDirector/PDMR Shareholding
8th Feb 20222:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.